% Generated by Paperpile. Check out http://paperpile.com for more information.
% BibTeX export options can be customized via Settings -> BibTeX.

@ARTICLE{Garzetti2017-os,
  title    = "{High-Quality} {Whole-Genome} Sequences of the
              {Oligo-Mouse-Microbiota} Bacterial Community",
  author   = "Garzetti, Debora and Brugiroux, Sandrine and Bunk, Boyke and
              Pukall, R{\"u}diger and McCoy, Kathy D and Macpherson, Andrew J
              and Stecher, B{\"a}rbel",
  abstract = "The Oligo-Mouse-Microbiota (Oligo-MM12) is a community of 12
              mouse intestinal bacteria to be used for microbiome research in
              gnotobiotic mice. We present here the high-quality whole genome
              sequences of the Oligo-MM12 strains, which were obtained by
              combining the accuracy of the Illumina platforms with the long
              reads of the PacBio technology.",
  journal  = "Genome Announc.",
  volume   =  5,
  number   =  42,
  month    =  oct,
  year     =  2017,
  language = "en"
}

@ARTICLE{Turnbaugh2007-cd,
  title    = "The human microbiome project",
  author   = "Turnbaugh, Peter J and Ley, Ruth E and Hamady, Micah and
              Fraser-Liggett, Claire M and Knight, Rob and Gordon, Jeffrey I",
  abstract = "A strategy to understand the microbial components of the human
              genetic and metabolic landscape and how they contribute to normal
              physiology and predisposition to disease.",
  journal  = "Nature",
  volume   =  449,
  number   =  7164,
  pages    = "804--810",
  month    =  oct,
  year     =  2007,
  language = "en"
}

@ARTICLE{Heintz-Buschart2018-xc,
  title    = "Human Gut Microbiome: Function Matters",
  author   = "Heintz-Buschart, Anna and Wilmes, Paul",
  abstract = "The human gut microbiome represents a complex ecosystem
              contributing essential functions to its host. Recent large-scale
              metagenomic studies have provided insights into its structure and
              functional potential. However, the functional repertoire which is
              actually contributed to human physiology remains largely
              unexplored. Here, by leveraging recent omics datasets, we
              challenge current assumptions regarding key attributes of the
              functional gut microbiome, in particular with respect to its
              variability. We further argue that the closing of existing gaps
              in functional knowledge should be addressed by a most-wanted gene
              list, the development and application of molecular and cellular
              high-throughput measurements, the development and sensible use of
              experimental models, as well as the direct study of observable
              molecular effects in the human host.",
  journal  = "Trends Microbiol.",
  volume   =  26,
  number   =  7,
  pages    = "563--574",
  month    =  jul,
  year     =  2018,
  keywords = "functional microbiome; metagenomics; metaproteomics;
              metatranscriptomics; microbiome variability and individuality;
              multi-omics",
  language = "en"
}

@ARTICLE{Schaedler1965-tg,
  title    = "{THE} {DEVELOPMENT} {OF} {THE} {BACTERIAL} {FLORA} {IN} {THE}
              {GASTROINTESTINAL} {TRACT} {OF} {MICE}",
  author   = "Schaedler, R W and Dubos, R and Costello, R",
  abstract = "Selective culture media, and equipment for anaerobic incubation
              of large numbers of specimens, have been developed to facilitate
              the quantitative enumeration of the various aerobic and anaerobic
              bacterial species present in the gastrointestinal tract. The
              evolution of this flora has been followed in young mice from
              several colonies by cultivating homogenates of the different
              parts of the gastrointestinal tract at daily intervals from the
              time of birth to the time of weaning. It has been found that the
              lactobacilli and anaerobic streptococci become established
              immediately after birth and persist in large numbers, not only in
              the large intestine but also in the stomach and in the small
              intestine. In contrast, the anaerobic bacilli of the bacteroides
              group become established only after the 16th day; they multiply
              only in the large intestine but persist in this organ in very
              large numbers. Other bacterial species become established at
              different periods of time after birth, exhibit characteristic
              anatomic localizations, and greatly fluctuate in numbers. In
              general, the populations of enterobacilli and enterococci
              decrease precipitously after having reached a maximum level
              shortly after the beginning of colonization.",
  journal  = "J. Exp. Med.",
  volume   =  122,
  pages    = "59--66",
  month    =  jul,
  year     =  1965,
  keywords = "ANIMALS, NEWBORN; BACTERIOLOGICAL TECHNICS; BACTEROIDES; CELL
              DIVISION; ESCHERICHIA COLI; EXPERIMENTAL LAB STUDY;
              FLAVOBACTERIUM; GROWTH; HOMOGENATES; INTESTINAL MICROORGANISMS;
              INTESTINE, LARGE; INTESTINE, SMALL; LACTOBACILLUS; MICE; STOMACH;
              STREPTOCOCCUS; WEANING",
  language = "en"
}

@ARTICLE{Kelly2016-ph,
  title    = "Effect of Fecal Microbiota Transplantation on Recurrence in
              Multiply Recurrent Clostridium difficile Infection: A Randomized
              Trial",
  author   = "Kelly, Colleen R and Khoruts, Alexander and Staley, Christopher
              and Sadowsky, Michael J and Abd, Mortadha and Alani, Mustafa and
              Bakow, Brianna and Curran, Patrizia and McKenney, Joyce and
              Tisch, Allison and Reinert, Steven E and Machan, Jason T and
              Brandt, Lawrence J",
  abstract = "Background: To date, evidence for the efficacy of fecal
              microbiota transplantation (FMT) in recurrent Clostridium
              difficile infection (CDI) has been limited to case series and
              open-label clinical trials. Objective: To determine the efficacy
              and safety of FMT for treatment of recurrent CDI. Design:
              Randomized, controlled, double-blind clinical trial.
              (ClinicalTrials.gov: NCT01703494). Setting: Two academic medical
              centers. Patients: 46 patients who had 3 or more recurrences of
              CDI and received a full course of vancomycin for their most
              recent acute episode. Intervention: Fecal microbiota
              transplantation with donor stool (heterologous) or patient's own
              stool (autologous) administered by colonoscopy. Measurements: The
              primary end point was resolution of diarrhea without the need for
              further anti-CDI therapy during the 8-week follow-up. Safety data
              were compared between treatment groups via review of adverse
              events (AEs), serious AEs (SAEs), and new medical conditions for
              6 months after FMT. Fecal microbiota analyses were performed on
              patients' stool before and after FMT and also on donors' stool.
              Results: In the intention-to-treat analysis, 20 of 22 patients
              (90.9\%) in the donor FMT group achieved clinical cure compared
              with 15 of 24 (62.5\%) in the autologous FMT group (P = 0.042).
              Resolution after autologous FMT differed by site (9 of 10 vs. 6
              of 14 [P = 0.033]). All 9 patients who developed recurrent CDI
              after autologous FMT were free of further CDI after subsequent
              donor FMT. There were no SAEs related to FMT. Donor FMT restored
              gut bacterial community diversity and composition to resemble
              that of healthy donors. Limitation: The study included only
              patients who had 3 or more recurrences and excluded those who
              were immunocompromised and aged 75 years or older. Conclusion:
              Donor stool administered via colonoscopy seemed safe and was more
              efficacious than autologous FMT in preventing further CDI
              episodes. Primary Funding Source: National Institute of Diabetes
              and Digestive and Kidney Diseases.",
  journal  = "Ann. Intern. Med.",
  volume   =  165,
  number   =  9,
  pages    = "609--616",
  month    =  nov,
  year     =  2016,
  language = "en"
}

@ARTICLE{Biggs2017-md,
  title    = "Managing uncertainty in metabolic network structure and improving
              predictions using {EnsembleFBA}",
  author   = "Biggs, Matthew B and Papin, Jason A",
  abstract = "Genome-scale metabolic network reconstructions (GENREs) are
              repositories of knowledge about the metabolic processes that
              occur in an organism. GENREs have been used to discover and
              interpret metabolic functions, and to engineer novel network
              structures. A major barrier preventing more widespread use of
              GENREs, particularly to study non-model organisms, is the
              extensive time required to produce a high-quality GENRE. Many
              automated approaches have been developed which reduce this time
              requirement, but automatically-reconstructed draft GENREs still
              require curation before useful predictions can be made. We
              present a novel approach to the analysis of GENREs which improves
              the predictive capabilities of draft GENREs by representing many
              alternative network structures, all equally consistent with
              available data, and generating predictions from this ensemble.
              This ensemble approach is compatible with many reconstruction
              methods. We refer to this new approach as Ensemble Flux Balance
              Analysis (EnsembleFBA). We validate EnsembleFBA by predicting
              growth and gene essentiality in the model organism Pseudomonas
              aeruginosa UCBPP-PA14. We demonstrate how EnsembleFBA can be
              included in a systems biology workflow by predicting essential
              genes in six Streptococcus species and mapping the essential
              genes to small molecule ligands from DrugBank. We found that some
              metabolic subsystems contributed disproportionately to the set of
              predicted essential reactions in a way that was unique to each
              Streptococcus species, leading to species-specific outcomes from
              small molecule interactions. Through our analyses of P.
              aeruginosa and six Streptococci, we show that ensembles increase
              the quality of predictions without drastically increasing
              reconstruction time, thus making GENRE approaches more practical
              for applications which require predictions for many non-model
              organisms. All of our functions and accompanying example code are
              available in an open online repository.",
  journal  = "PLoS Comput. Biol.",
  volume   =  13,
  number   =  3,
  pages    = "e1005413",
  month    =  mar,
  year     =  2017,
  keywords = "ensembles",
  language = "en"
}

@ARTICLE{Wymore_Brand2015-ez,
  title    = "The Altered Schaedler Flora: Continued Applications of a Defined
              Murine Microbial Community",
  author   = "Wymore Brand, Meghan and Wannemuehler, Michael J and Phillips,
              Gregory J and Proctor, Alexandra and Overstreet, Anne-Marie and
              Jergens, Albert E and Orcutt, Roger P and Fox, James G",
  abstract = "The gastrointestinal (GI) microbiota forms a mutualistic
              relationship with the host through complex and dynamic
              interactions. Because of the complexity and interindividual
              variation of the GI microbiota, investigating how members of the
              microbiota interact with each other, as well as with the host, is
              daunting. The altered Schaedler flora (ASF) is a model community
              of eight microorganisms that was developed by R.P. Orcutt and has
              been in use since the late 1970s. The eight microorganisms
              composing the ASF were all derived from mice, can be cultured in
              vitro, and are stably passed through multiple generations (at
              least 15 years or more by the authors) in gnotobiotic mice
              continually bred in isolator facilities. With the limitations
              associated with conventional, mono- or biassociated, and germfree
              mice, use of mice colonized with a consortium of known bacteria
              that naturally inhabit the murine gut offers a powerful system to
              investigate mechanisms governing host-microbiota relationships,
              and how members of the GI microbiota interact with one another.
              The ASF community offers significant advantages to study
              homeostatic as well as disease-related interactions by taking
              advantage of a well-defined, limited community of microorganisms.
              For example, quantification and spatial distribution of
              individual members, microbial genetic manipulation, genomic-scale
              analysis, and identification of microorganism-specific host
              immune responses are all achievable using the ASF model. This
              review compiles highlights associated with the 37-year history of
              the ASF, including descriptions of its continued use in
              biomedical research to elucidate the complexities of
              host-microbiome interactions in health and disease.",
  journal  = "ILAR J.",
  volume   =  56,
  number   =  2,
  pages    = "169--178",
  year     =  2015,
  keywords = "ASF; gnotobiotic; microbiota",
  language = "en"
}

@ARTICLE{Biggs2015-lz,
  title    = "Metabolic network modeling of microbial communities",
  author   = "Biggs, Matthew B and Medlock, Gregory L and Kolling, Glynis L and
              Papin, Jason A",
  abstract = "Genome-scale metabolic network reconstructions and
              constraint-based analyses are powerful methods that have the
              potential to make functional predictions about microbial
              communities. Genome-scale metabolic networks are used to
              characterize the metabolic functions of microbial communities via
              several techniques including species compartmentalization,
              separating species-level and community-level objectives, dynamic
              analysis, the 'enzyme-soup' approach, multiscale modeling, and
              others. There are many challenges in the field, including a need
              for tools that accurately assign high-level omics signals to
              individual community members, the need for improved automated
              network reconstruction methods, and novel algorithms for
              integrating omics data and engineering communities. As
              technologies and modeling frameworks improve, we expect that
              there will be corresponding advances in the fields of ecology,
              health science, and microbial community engineering.",
  journal  = "Wiley Interdiscip. Rev. Syst. Biol. Med.",
  volume   =  7,
  number   =  5,
  pages    = "317--334",
  month    =  sep,
  year     =  2015,
  language = "en"
}

@ARTICLE{Brugiroux2016-vi,
  title    = "Genome-guided design of a defined mouse microbiota that confers
              colonization resistance against Salmonella enterica serovar
              Typhimurium",
  author   = "Brugiroux, Sandrine and Beutler, Markus and Pfann, Carina and
              Garzetti, Debora and Ruscheweyh, Hans-Joachim and Ring, Diana and
              Diehl, Manuel and Herp, Simone and L{\"o}tscher, Yvonne and
              Hussain, Saib and Bunk, Boyke and Pukall, R{\"u}diger and Huson,
              Daniel H and M{\"u}nch, Philipp C and McHardy, Alice C and McCoy,
              Kathy D and Macpherson, Andrew J and Loy, Alexander and Clavel,
              Thomas and Berry, David and Stecher, B{\"a}rbel",
  abstract = "Protection against enteric infections, also termed colonization
              resistance, results from mutualistic interactions of the host and
              its indigenous microbes. The gut microbiota of humans and mice is
              highly diverse and it is therefore challenging to assign specific
              properties to its individual members. Here, we have used a
              collection of murine bacterial strains and a modular design
              approach to create a minimal bacterial community that, once
              established in germ-free mice, provided colonization resistance
              against the human enteric pathogen Salmonella enterica serovar
              Typhimurium (S. Tm). Initially, a community of 12 strains, termed
              Oligo-Mouse-Microbiota (Oligo-MM12), representing members of the
              major bacterial phyla in the murine gut, was selected. This
              community was stable over consecutive mouse generations and
              provided colonization resistance against S. Tm infection, albeit
              not to the degree of a conventional complex microbiota.
              Comparative (meta)genome analyses identified functions
              represented in a conventional microbiome but absent from the
              Oligo-MM12. By genome-informed design, we created an improved
              version of the Oligo-MM community harbouring three facultative
              anaerobic bacteria from the mouse intestinal bacterial collection
              (miBC) that provided conventional-like colonization resistance.
              In conclusion, we have established a highly versatile
              experimental system that showed efficacy in an enteric infection
              model. Thus, in combination with exhaustive bacterial strain
              collections and systems-based approaches, genome-guided design
              can be used to generate insights into microbe-microbe and
              microbe-host interactions for the investigation of ecological and
              disease-relevant mechanisms in the intestine.",
  journal  = "Nat Microbiol",
  volume   =  2,
  pages    = "16215",
  month    =  nov,
  year     =  2016,
  language = "en"
}

@ARTICLE{Young2017-xs,
  title    = "The role of the microbiome in human health and disease: an
              introduction for clinicians",
  author   = "Young, Vincent B",
  abstract = "Research into the microbiome-the indigenous microbial communities
              (microbiota) and the host environment that they inhabit-has
              changed clinicians' ideas about microbes in human health and
              disease. Perhaps the most radical change is the realization that
              most of the microbes that inhabit our body supply crucial
              ecosystem services that benefit the entire host-microbe system.
              These services include the production of important resources,
              bioconversion of nutrients, and protection against pathogenic
              microbes. Thus disease can result from a loss of beneficial
              functions or the introduction of maladaptive functions by
              invading microbes. This review will show how an understanding of
              the dynamics and function of the indigenous microbiota has
              altered our view of microbes in maintaining homeostasis and
              causing disease. It will discuss how disruption of the beneficial
              functions of the microbiota can lead to disease. Methods for
              studying the microbiota will be introduced as part of a
              conceptual framework for using these methods to delineate novel
              roles for microbes in health. Key associations between specific
              changes in the microbiome and disease will be discussed. This
              will lead to an explanation of how the intentional manipulation
              of the microbiota, either by restoring missing functions or
              eliminating harmful functions, may lead to novel methods to
              prevent or treat a variety of diseases. With the explosion of
              studies relating the microbiome to health and disease, this
              review aims to provide a foundation for clinicians to follow this
              developing area of biomedical research.",
  journal  = "BMJ",
  volume   =  356,
  pages    = "j831",
  month    =  mar,
  year     =  2017,
  language = "en"
}

@ARTICLE{Douglas2018-oj,
  title    = "Which experimental systems should we use for human microbiome
              science?",
  author   = "Douglas, Angela E",
  abstract = "Microbiome science is revealing that the phenotype and health of
              animals, including humans, depend on the sustained function of
              their resident microorganisms. In this essay, I argue for
              thoughtful choice of model systems for human microbiome science.
              A greater variety of experimental systems, including wider use of
              invertebrate models, would benefit biomedical research, while
              systems ill-suited to experimental and genetic manipulation can
              be used to address very limited sets of scientific questions.
              Microbiome science benefits from the coordinated use of multiple
              systems, which is facilitated by networks of researchers with
              expertise in different experimental systems.",
  journal  = "PLoS Biol.",
  volume   =  16,
  number   =  3,
  pages    = "e2005245",
  month    =  mar,
  year     =  2018,
  language = "en"
}

@ARTICLE{Medlock2018-ub,
  title    = "Inferring Metabolic Mechanisms of Interaction within a Defined
              Gut Microbiota",
  author   = "Medlock, Gregory L and Carey, Maureen A and McDuffie, Dennis G
              and Mundy, Michael B and Giallourou, Natasa and Swann, Jonathan R
              and Kolling, Glynis L and Papin, Jason A",
  abstract = "The diversity and number of species present within microbial
              communities create the potential for a multitude of interspecies
              metabolic interactions. Here, we develop, apply, and
              experimentally test a framework for inferring metabolic
              mechanisms associated with interspecies interactions. We perform
              pairwise growth and metabolome profiling of co-cultures of
              strains from a model mouse microbiota. We then apply our
              framework to dissect emergent metabolic behaviors that occur in
              co-culture. Based on one of the inferences from this framework,
              we identify and interrogate an amino acid cross-feeding
              interaction and validate that the proposed interaction leads to a
              growth benefit in vitro. Our results reveal the type and extent
              of emergent metabolic behavior in microbial communities composed
              of gut microbes. We focus on growth-modulating interactions, but
              the framework can be applied to interspecies interactions that
              modulate any phenotype of interest within microbial communities.",
  journal  = "Cell Syst",
  volume   =  7,
  number   =  3,
  pages    = "245--257.e7",
  month    =  sep,
  year     =  2018,
  keywords = "emergent behavior; interspecies interactions; mathematical
              modeling; metabolic cross-feeding; metabolism; microbial
              community; microbial ecology; microbiome; microbiota; systems
              biology",
  language = "en"
}

@ARTICLE{Leonard2018-pq,
  title    = "Genetic Engineering of Bee Gut Microbiome Bacteria with a Toolkit
              for Modular Assembly of {Broad-Host-Range} Plasmids",
  author   = "Leonard, Sean P and Perutka, Jiri and Powell, J Elijah and Geng,
              Peng and Richhart, Darby D and Byrom, Michelle and Kar, Shaunak
              and Davies, Bryan W and Ellington, Andrew D and Moran, Nancy A
              and Barrick, Jeffrey E",
  abstract = "Engineering the bacteria present in animal microbiomes promises
              to lead to breakthroughs in medicine and agriculture, but
              progress is hampered by a dearth of tools for genetically
              modifying the diverse species that comprise these communities.
              Here we present a toolkit of genetic parts for the modular
              construction of broad-host-range plasmids built around the
              RSF1010 replicon. Golden Gate assembly of parts in this toolkit
              can be used to rapidly test various antibiotic resistance
              markers, promoters, fluorescent reporters, and other coding
              sequences in newly isolated bacteria. We demonstrate the utility
              of this toolkit in multiple species of Proteobacteria that are
              native to the gut microbiomes of honey bees ( Apis mellifera) and
              bumble bees (B ombus sp.). Expressing fluorescent proteins in
              Snodgrassella alvi, Gilliamella apicola, Bartonella apis, and
              Serratia strains enables us to visualize how these bacteria
              colonize the bee gut. We also demonstrate CRISPRi repression in
              B. apis and use Cas9-facilitated knockout of an S. alvi adhesion
              gene to show that it is important for colonization of the gut.
              Beyond characterizing how the gut microbiome influences the
              health of these prominent pollinators, this bee microbiome
              toolkit (BTK) will be useful for engineering bacteria found in
              other natural microbial communities.",
  journal  = "ACS Synth. Biol.",
  volume   =  7,
  number   =  5,
  pages    = "1279--1290",
  month    =  may,
  year     =  2018,
  keywords = "colony collapse disorder; host-associated microbiome; probiotics;
              symbiotic bacteria",
  language = "en"
}

@ARTICLE{OToole2017-th,
  title    = "Next-generation probiotics: the spectrum from probiotics to live
              biotherapeutics",
  author   = "O'Toole, Paul W and Marchesi, Julian R and Hill, Colin",
  abstract = "The leading probiotics currently available to consumers are
              generally drawn from a narrow range of organisms. Knowledge of
              the gut microbiota and its constituent actors is changing this
              paradigm, particularly given the phylogenetic range and
              relatively unknown characteristics of the organisms under
              investigation as novel therapeutics. For this reason, and because
              their development is likely to be more amenable to a
              pharmaceutical than a food delivery route, these organisms are
              often operationally referred to as next-generation probiotics, a
              concept that overlaps with the emerging concept of live
              biotherapeutic products. The latter is a class of organisms
              developed exclusively for pharmaceutical application. In this
              Perspective, we discuss what lessons have been learned from
              working with traditional probiotics, explore the kinds of
              organisms that are likely to be used as novel microbial
              therapeutics, discuss the regulatory framework required, and
              propose how scientists may meet this challenge.",
  journal  = "Nat Microbiol",
  volume   =  2,
  pages    = "17057",
  month    =  apr,
  year     =  2017,
  language = "en"
}

@ARTICLE{Tramontano2018-xz,
  title    = "Nutritional preferences of human gut bacteria reveal their
              metabolic idiosyncrasies",
  author   = "Tramontano, Melanie and Andrejev, Sergej and Pruteanu, Mihaela
              and Kl{\"u}nemann, Martina and Kuhn, Michael and Galardini, Marco
              and Jouhten, Paula and Zelezniak, Aleksej and Zeller, Georg and
              Bork, Peer and Typas, Athanasios and Patil, Kiran Raosaheb",
  abstract = "Bacterial metabolism plays a fundamental role in gut microbiota
              ecology and host-microbiome interactions. Yet the metabolic
              capabilities of most gut bacteria have remained unknown. Here we
              report growth characteristics of 96 phylogenetically diverse gut
              bacterial strains across 4 rich and 15 defined media. The vast
              majority of strains (76) grow in at least one defined medium,
              enabling accurate assessment of their biosynthetic capabilities.
              These do not necessarily match phylogenetic similarity, thus
              indicating a complex evolution of nutritional preferences. We
              identify mucin utilizers and species inhibited by amino acids and
              short-chain fatty acids. Our analysis also uncovers media for in
              vitro studies wherein growth capacity correlates well with in
              vivo abundance. Further value of the underlying resource is
              demonstrated by correcting pathway gaps in available genome-scale
              metabolic models of gut microorganisms. Together, the media
              resource and the extracted knowledge on growth abilities widen
              experimental and computational access to the gut microbiota.",
  journal  = "Nat Microbiol",
  volume   =  3,
  number   =  4,
  pages    = "514--522",
  month    =  apr,
  year     =  2018,
  language = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Robaina-Estevez2017-fy,
  title    = "On the effects of alternative optima in context-specific
              metabolic model predictions",
  author   = "Robaina-Est{\'e}vez, Semid{\'a}n and Nikoloski, Zoran",
  abstract = "The integration of experimental data into genome-scale metabolic
              models can greatly improve flux predictions. This is achieved by
              restricting predictions to a more realistic context-specific
              domain, like a particular cell or tissue type. Several
              computational approaches to integrate data have been
              proposed-generally obtaining context-specific (sub)models or flux
              distributions. However, these approaches may lead to a multitude
              of equally valid but potentially different models or flux
              distributions, due to possible alternative optima in the
              underlying optimization problems. Although this issue introduces
              ambiguity in context-specific predictions, it has not been
              generally recognized, especially in the case of model
              reconstructions. In this study, we analyze the impact of
              alternative optima in four state-of-the-art context-specific data
              integration approaches, providing both flux distributions and/or
              metabolic models. To this end, we present three computational
              methods and apply them to two particular case studies:
              leaf-specific predictions from the integration of gene expression
              data in a metabolic model of Arabidopsis thaliana, and
              liver-specific reconstructions derived from a human model with
              various experimental data sources. The application of these
              methods allows us to obtain the following results: (i) we sample
              the space of alternative flux distributions in the leaf- and the
              liver-specific case and quantify the ambiguity of the
              predictions. In addition, we show how the inclusion of
              â„“1-regularization during data integration reduces the ambiguity
              in both cases. (ii) We generate sets of alternative leaf- and
              liver-specific models that are optimal to each one of the
              evaluated model reconstruction approaches. We demonstrate that
              alternative models of the same context contain a marked fraction
              of disparate reactions. Further, we show that a careful balance
              between model sparsity and metabolic functionality helps in
              reducing the discrepancies between alternative models. Finally,
              our findings indicate that alternative optima must be taken into
              account for rendering the context-specific metabolic model
              predictions less ambiguous.",
  journal  = "PLoS Comput. Biol.",
  volume   =  13,
  number   =  5,
  pages    = "e1005568",
  month    =  may,
  year     =  2017,
  language = "en"
}

@ARTICLE{Joice2014-tp,
  title    = "Determining microbial products and identifying molecular targets
              in the human microbiome",
  author   = "Joice, Regina and Yasuda, Koji and Shafquat, Afrah and Morgan,
              Xochitl C and Huttenhower, Curtis",
  abstract = "Human-associated microbes are the source of many bioactive
              microbial products (proteins and metabolites) that play key
              functions both in human host pathways and in microbe-microbe
              interactions. Culture-independent studies now provide an
              accelerated means of exploring novel bioactives in the human
              microbiome; however, intriguingly, a substantial fraction of the
              microbial metagenome cannot be mapped to annotated genes or
              isolate genomes and is thus of unknown function. Meta'omic
              approaches, including metagenomic sequencing,
              metatranscriptomics, metabolomics, and integration of multiple
              assay types, represent an opportunity to efficiently explore this
              large pool of potential therapeutics. In combination with
              appropriate follow-up validation, high-throughput
              culture-independent assays can be combined with computational
              approaches to identify and characterize novel and biologically
              interesting microbial products. Here we briefly review the state
              of microbial product identification and characterization and
              discuss possible next steps to catalog and leverage the large
              uncharted fraction of the microbial metagenome.",
  journal  = "Cell Metab.",
  volume   =  20,
  number   =  5,
  pages    = "731--741",
  month    =  nov,
  year     =  2014,
  language = "en"
}

@ARTICLE{Gilbert2016-oe,
  title    = "Microbiome-wide association studies link dynamic microbial
              consortia to disease",
  author   = "Gilbert, Jack A and Quinn, Robert A and Debelius, Justine and Xu,
              Zhenjiang Z and Morton, James and Garg, Neha and Jansson, Janet K
              and Dorrestein, Pieter C and Knight, Rob",
  abstract = "Rapid advances in DNA sequencing, metabolomics, proteomics and
              computational tools are dramatically increasing access to the
              microbiome and identification of its links with disease. In
              particular, time-series studies and multiple molecular
              perspectives are facilitating microbiome-wide association
              studies, which are analogous to genome-wide association studies.
              Early findings point to actionable outcomes of microbiome-wide
              association studies, although their clinical application has yet
              to be approved. An appreciation of the complexity of interactions
              among the microbiome and the host's diet, chemistry and health,
              as well as determining the frequency of observations that are
              needed to capture and integrate this dynamic interface, is
              paramount for developing precision diagnostics and therapies that
              are based on the microbiome.",
  journal  = "Nature",
  volume   =  535,
  number   =  7610,
  pages    = "94--103",
  month    =  jul,
  year     =  2016,
  language = "en"
}

@ARTICLE{Monk2014-fa,
  title    = "Optimizing genome-scale network reconstructions",
  author   = "Monk, Jonathan and Nogales, Juan and Palsson, Bernhard O",
  journal  = "Nat. Biotechnol.",
  volume   =  32,
  number   =  5,
  pages    = "447--452",
  month    =  may,
  year     =  2014,
  language = "en"
}

@ARTICLE{Loy2017-rb,
  title    = "Lifestyle and Horizontal Gene {Transfer-Mediated} Evolution of
              Mucispirillum schaedleri, a Core Member of the Murine Gut
              Microbiota",
  author   = "Loy, Alexander and Pfann, Carina and Steinberger, Michaela and
              Hanson, Buck and Herp, Simone and Brugiroux, Sandrine and Gomes
              Neto, Jo{\~a}o Carlos and Boekschoten, Mark V and Schwab,
              Clarissa and Urich, Tim and Ramer-Tait, Amanda E and Rattei,
              Thomas and Stecher, B{\"a}rbel and Berry, David",
  abstract = "Mucispirillum schaedleri is an abundant inhabitant of the
              intestinal mucus layer of rodents and other animals and has been
              suggested to be a pathobiont, a commensal that plays a role in
              disease. In order to gain insights into its lifestyle, we
              analyzed the genome and transcriptome of M. schaedleri ASF 457
              and performed physiological experiments to test traits predicted
              by its genome. Although described as a mucus inhabitant, M.
              schaedleri has limited capacity for degrading host-derived
              mucosal glycans and other complex polysaccharides. Additionally,
              M. schaedleri reduces nitrate and expresses systems for
              scavenging oxygen and reactive oxygen species in vivo, which may
              account for its localization close to the mucosal tissue and
              expansion during inflammation. Also of note, M. schaedleri
              harbors a type VI secretion system and putative effector proteins
              and can modify gene expression in mucosal tissue, suggesting
              intimate interactions with its host and a possible role in
              inflammation. The M. schaedleri genome has been shaped by
              extensive horizontal gene transfer, primarily from intestinal
              Epsilon- and Deltaproteobacteria, indicating that horizontal gene
              transfer has played a key role in defining its niche in the gut
              ecosystem. IMPORTANCE Shifts in gut microbiota composition have
              been associated with intestinal inflammation, but it remains
              unclear whether inflammation-associated bacteria are commensal or
              detrimental to their host. Here, we studied the lifestyle of the
              gut bacterium Mucispirillum schaedleri, which is associated with
              inflammation in widely used mouse models. We found that M.
              schaedleri has specialized systems to handle oxidative stress
              during inflammation. Additionally, it expresses secretion systems
              and effector proteins and can modify the mucosal gene expression
              of its host. This suggests that M. schaedleri undergoes intimate
              interactions with its host and may play a role in inflammation.
              The insights presented here aid our understanding of how
              commensal gut bacteria may be involved in altering susceptibility
              to disease.",
  journal  = "mSystems",
  volume   =  2,
  number   =  1,
  month    =  jan,
  year     =  2017,
  keywords = "DNRA; Deferribacteres; Helicobacter; fluorescence in situ
              hybridization; gut microbiota; metatranscriptomics",
  language = "en"
}

@ARTICLE{Biggs2017-fs,
  title    = "Systems-level metabolism of the altered Schaedler flora, a
              complete gut microbiota",
  author   = "Biggs, Matthew B and Medlock, Gregory L and Moutinho, Thomas J
              and Lees, Hannah J and Swann, Jonathan R and Kolling, Glynis L
              and Papin, Jason A",
  abstract = "The altered Schaedler flora (ASF) is a model microbial community
              with both in vivo and in vitro relevance. Here we provide the
              first characterization of the ASF community in vitro, independent
              of a murine host. We compared the functional genetic content of
              the ASF to wild murine metagenomes and found that the ASF
              functionally represents wild microbiomes better than random
              consortia of similar taxonomic composition. We developed a
              chemically defined medium that supported growth of seven of the
              eight ASF members. To elucidate the metabolic capabilities of
              these ASF species-including potential for interactions such as
              cross-feeding-we performed a spent media screen and analyzed the
              results through dynamic growth measurements and non-targeted
              metabolic profiling. We found that cross-feeding is relatively
              rare (32 of 3570 possible cases), but is enriched between
              Clostridium ASF356 and Parabacteroides ASF519. We identified many
              cases of emergent metabolism (856 of 3570 possible cases). These
              data will inform efforts to understand ASF dynamics and spatial
              distribution in vivo, to design pre- and probiotics that modulate
              relative abundances of ASF members, and will be essential for
              validating computational models of ASF metabolism.
              Well-characterized, experimentally tractable microbial
              communities enable research that can translate into more
              effective microbiome-targeted therapies to improve human health.",
  journal  = "ISME J.",
  volume   =  11,
  number   =  2,
  pages    = "426--438",
  month    =  feb,
  year     =  2017,
  language = "en"
}

@ARTICLE{Ivanov2008-cl,
  title    = "Specific microbiota direct the differentiation of
              {IL-17-producing} T-helper cells in the mucosa of the small
              intestine",
  author   = "Ivanov, Ivaylo I and Frutos, Rosa de Llanos and Manel, Nicolas
              and Yoshinaga, Keiji and Rifkin, Daniel B and Sartor, R Balfour
              and Finlay, B Brett and Littman, Dan R",
  abstract = "The requirements for in vivo steady state differentiation of
              IL-17-producing T-helper (Th17) cells, which are potent
              inflammation effectors, remain obscure. We report that Th17 cell
              differentiation in the lamina propria (LP) of the small intestine
              requires specific commensal microbiota and is inhibited by
              treating mice with selective antibiotics. Mice from different
              sources had marked differences in their Th17 cell numbers and
              animals lacking Th17 cells acquired them after introduction of
              bacteria from Th17 cell-sufficient mice. Differentiation of Th17
              cells correlated with the presence of
              cytophaga-flavobacter-bacteroidetes (CFB) bacteria in the
              intestine and was independent of toll-like receptor, IL-21 or
              IL-23 signaling, but required appropriate TGF-beta activation.
              Absence of Th17 cell-inducing bacteria was accompanied by
              increase in Foxp3+ regulatory T cells (Treg) in the LP. Our
              results suggest that composition of intestinal microbiota
              regulates the Th17:Treg balance in the LP and may thus influence
              intestinal immunity, tolerance, and susceptibility to
              inflammatory bowel diseases.",
  journal  = "Cell Host Microbe",
  volume   =  4,
  number   =  4,
  pages    = "337--349",
  month    =  oct,
  year     =  2008,
  language = "en"
}
